• Je něco špatně v tomto záznamu ?

Microrna-122 as a biomarker associated with oxidative stress in patients suffering from metabolic diseases

Ruqaya S. Reda, Nawal Khinteel Jabbar

. 2024 ; 93 (2) : 167-175. [pub] 20240603

Jazyk angličtina Země Česko

Typ dokumentu klinická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc24010005

Background: Recent evidence has shown that circulating microribonucleic acid (miRNA) has been related to many diseases either as an inhibitor or a stimulant factor, among them miRNA-122 which has proven through studies its relationship with insulin resistance, an adversative lipid profile, obesity, type 2 diabetes, and metabolic syndrome in several studies; however, the mechanisms involved are unknown. This study investigates the role of miRNA-122 expression in overweight patients suffering from metabolic disorders such as diabetes and hypertension and its relationship to the development of oxidative stress in patient groups.Materials and Methods: 30 patients with type 2 diabetes mellitus (T2DM), 30 people with hypertension (HTN), 30 patients with T2DM+HTN, and 30 healthy persons who served as controls were enrolled in this study. An ARCHITECT c4000 clinical chemistry analyzer was used to assess lipid profiles. The sandwich immunodetection approach was used to assess whole blood hemoglobinA1c. By colorimetric methodology, catalase activity (CAT), superoxide dismutase activity (SOD), malondialdehyde (MDA) levels, and advanced oxidation protein products (AOPPs) levels were measured. The expression of serum miRNA-122 was determined using the quantitative polymerase chain reaction.Results: The activity of SOD and CAT in patient groups was found to be substantially lower than in the control group (p < 0.05), whereas MDA and AOPP concentrations were found to be significantly higher in patient groups compared to the control group (p < 0.05). When patient groups were compared to control groups, the miRNA-122 level was higher in the patients (p< 0.05).Conclusions: miRNA-122 expression is involved in the pathogenesis of T2DM and HTN-induced oxidative stress, there is a reciprocal relationship between the increase in gene expression of the miRNA-122 and the increase in oxidative stress accompanied by a decrease in the effectiveness of antioxidant enzymes, which leads to the development of the disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24010005
003      
CZ-PrNML
005      
20241116215122.0
007      
ta
008      
241008s2024 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.31482/mmsl.2023.020 $2 doi
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Reda, Ruqaya S. $u Department of Chemistry, College of Sciences, University of Al Qadisiyah, University street, 1, Al Qadisiyah, Iraq
245    10
$a Microrna-122 as a biomarker associated with oxidative stress in patients suffering from metabolic diseases / $c Ruqaya S. Reda, Nawal Khinteel Jabbar
520    9_
$a Background: Recent evidence has shown that circulating microribonucleic acid (miRNA) has been related to many diseases either as an inhibitor or a stimulant factor, among them miRNA-122 which has proven through studies its relationship with insulin resistance, an adversative lipid profile, obesity, type 2 diabetes, and metabolic syndrome in several studies; however, the mechanisms involved are unknown. This study investigates the role of miRNA-122 expression in overweight patients suffering from metabolic disorders such as diabetes and hypertension and its relationship to the development of oxidative stress in patient groups.Materials and Methods: 30 patients with type 2 diabetes mellitus (T2DM), 30 people with hypertension (HTN), 30 patients with T2DM+HTN, and 30 healthy persons who served as controls were enrolled in this study. An ARCHITECT c4000 clinical chemistry analyzer was used to assess lipid profiles. The sandwich immunodetection approach was used to assess whole blood hemoglobinA1c. By colorimetric methodology, catalase activity (CAT), superoxide dismutase activity (SOD), malondialdehyde (MDA) levels, and advanced oxidation protein products (AOPPs) levels were measured. The expression of serum miRNA-122 was determined using the quantitative polymerase chain reaction.Results: The activity of SOD and CAT in patient groups was found to be substantially lower than in the control group (p &lt; 0.05), whereas MDA and AOPP concentrations were found to be significantly higher in patient groups compared to the control group (p &lt; 0.05). When patient groups were compared to control groups, the miRNA-122 level was higher in the patients (p&lt; 0.05).Conclusions: miRNA-122 expression is involved in the pathogenesis of T2DM and HTN-induced oxidative stress, there is a reciprocal relationship between the increase in gene expression of the miRNA-122 and the increase in oxidative stress accompanied by a decrease in the effectiveness of antioxidant enzymes, which leads to the development of the disease.
650    07
$a dospělí $7 D000328 $2 czmesh
650    07
$a lidé $7 D006801 $2 czmesh
650    07
$a lidé středního věku $7 D008875 $2 czmesh
650    17
$a mikro RNA $x krev $7 D035683 $2 czmesh
650    07
$a biologické markery $x krev $7 D015415 $2 czmesh
650    07
$a oxidační stres $7 D018384 $2 czmesh
650    17
$a metabolické nemoci $x krev $x patologie $7 D008659 $2 czmesh
650    07
$a superoxiddismutasa $x krev $7 D013482 $2 czmesh
650    07
$a malondialdehyd $x krev $7 D008315 $2 czmesh
650    07
$a produkty pokročilé oxidace proteinů $x krev $7 D062107 $2 czmesh
650    07
$a biochemická analýza krve $x metody $x přístrojové vybavení $x statistika a číselné údaje $7 D001774 $2 czmesh
655    _7
$a klinická studie $7 D000068397 $2 czmesh
700    1_
$a Khinteel Jabbar, Nawal $u Department of Chemistry, College of Sciences, University of Al Qadisiyah, University street, 1, Al Qadisiyah, Iraq
773    0_
$t Vojenské zdravotnické listy $x 0372-7025 $g Roč. 93, č. 2 (2024), s. 167-175 $w MED00011116
856    41
$u https://mmsl.cz/artkey/mms-202402-0003_microrna-122-as-a-biomarker-associated-with-oxidative-stress-in-patients-suffering-from-metabolic-diseases.php $y plný text volně přístupný
910    __
$a ABA008 $b A 3 $c 1073 $y p $z 0
990    __
$a 20240606 $b ABA008
991    __
$a 20241116215112 $b ABA008
999    __
$a ok $b bmc $g 2203018 $s 1219835
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2024 $b 93 $c 2 $d 167-175 $e 20240603 $i 0372-7025 $m Vojenské zdravotnické listy $x MED00011116
LZP    __
$c NLK189 $d 20241116 $b NLK111 $a Actavia-MED00011116-20240606

Najít záznam

Citační ukazatele

Možnosti archivace